VBI Vaccines Announces Phase 2a Clinical Evaluation of VBI-1901 Cancer Vaccine Candidate in Combination with GSK's AS01B Adjuvant System in Recurrent Glioblastoma Patients

Stock Information for VBI Vaccines Inc.

Loading

Please wait while we load your information from QuoteMedia.